Fig. 3
From: Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography

Interaction modes of the residues at positions 2.50 and 7.49 and functional assays of NK1R mutants. a Strong hydrogen-bond interaction between D782.50 and N3017.49 (2.8 Å) and weak interaction between N782.50 and N3017.49 (3.5 Å). Two NK1R structures are shown in cartoon representation and colored green (E782.50D mutant) and cyan (E782.50N mutant). The residues at positions 2.50 and 7.49 are shown as sticks. b SP-induced cAMP accumulation measurements of the wild-type (WT) NK1R and the mutants E782.50D, N3017.49Q, E782.50D/N3017.49Q, E782.50N, N3017.49E, and E782.50N/N3017.49E. Dose–response curves were generated from at least three independent experiments performed in triplicate. Data shown are mean ± s.e.m. See Supplementary Table 3 for detailed statistical evaluation. c SP-induced IP1 accumulation of the WT NK1R and the mutants E782.50D, N3017.49Q, E782.50D/N3017.49Q, E782.50N, N3017.49E, and E782.50N/N3017.49E. Dose–response curves were generated from at least three independent experiments performed in triplicate or duplicate. Data shown are mean ± s.e.m. See Supplementary Table 2 for detailed statistical evaluation. Source data for Fig. 3b, c are provided as a Source Data file